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In recent years natural polymers have been widely used because of their effectiveness
and availability over synthetic polymers. In this present investigation matrix tablets of
Metformin hydrochloride were formulated using Water hyacinth powder and its rate
retardant activity was studied. Tablets were prepared using wet granulation method with
8% starch as granulating agent and 5, 10, 15, 20, 25 and 30% of Water hyacinth powder
to the drug. In preformulation study, angle of repose, Carr’s Index and Hausner ratio
were calculated. Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning
Calorimetry (DSC), and Scanning Electron Microscopy (SEM) studies were performed
and no interactions were found between drug and excipients. Weight variation, friability,
hardness, thickness, diameter, and in vitro release study were performed with the
prepared matrix tablets. Dissolution studies were conducted using USP type II apparatus
at a speed of 100 rpm at 37◦C ± 0.5 temperature for 8 h. Though all the formulations
comply with both BP and USP requirements, formulation F-1 (5% of Water hyacinth)
was the best fitted formula. The drug release patterns were explained in different kinetic
models such as Zero order, First order, Higuchi, Hixson Crowell, and Korsmeyer-Peppas
equations. The current investigation implies that Water hyacinth has the potential to be
used as a rate-retarding agent in sustained release drug formulations.
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INTRODUCTION
Water hyacinth [Eichhornia crassipes (Mart.) Solms], is a free
floating aquatic plant species belonging to the pickerelweed fam-
ily (Pontederiaceae) (Wang et al., 2012). It has attracted world-
wide attention due to its capability to grow very rapidly and
under optimal growing conditions, it takes 6–28 days to dou-
ble in weight and 4–58 days to double in number based on
field measurements (Gopal, 1987; Malik, 2007). In areas that are
predominantly influenced by aquatic life, this fast spread and
congested growth lead to serious problems in navigation, irri-
gation, power generation, and eventually on the environment,
human health, and economic development (Fernández et al.,
1990; Epstein, 1998). The plant has invaded many tropical lakes
including Lake Victoria, and East Africa where it caused several
problems such as reduction in fish catch, interference with trans-
portation and water supply and breeding of snails, mosquitoes,
and snakes (Mailu, 2001; Mironga, 2004).
On the other hand, when looked from a resource perspective,
it appears to be a valuable resource with several unique properties
like its extensive root system by which it can consume pollu-
tants such as ammonia, phosphates, nitrates, and other metal ion
(Wolverton and McDonald, 1981; Reddy and DeBusk, 1987). As
a result, one of its prime utility that has been found worldwide
acceptance is in treating wastewaters (Tchobanoglous et al., 1989)
and widely used for treatment of sewage and other nutrient rich
wastewater like agricultural drainage (Reddy et al., 1982), sewage
treatment (Sinha and Sinha, 2000), dairy effluent (Tripathi and
Upadhyay, 2003), and also industrial effluent from Textile mill
(Trivedy and Gudekar, 1987), paper mill (Menon et al., 2005) etc.
In a study it has been showed that Water hyacinth contains
60% cellulose, 8% hemicellulose, and 17% lignin (Abdel-Fattah
and Abdel-Naby, 2012). Both the cellulose and hemicelluloses are
polymers of sugars, and are thereby a potential source of sug-
ars (Xie et al., 2012), which can be further used for production
of ethanol, xylitol, organic acids, and other chemicals (Xia and
Sheng, 2004; Chen et al., 2008). As a result, research concerning
control and utilization of Water hyacinth has boomed up in the
last few decades.
During the last two decades there has been remarkable increase
in interest in sustained release drug delivery systems as it offers the
promise for reducing dosing frequency, maximizing the efficacy–
dose relationship, and decreasing adverse side effects (Wu and Jin,
2008). Both synthetic and natural polymers have been successfully
investigated in the formulation of solid, liquid, and semi-solid
dosage forms and in the design of novel drug delivery systems.
Many researchers have explored the usefulness of plant-based
materials like various natural gums and mucilages as pharma-
ceutical excipients. Ability to produce a wide range of materials
based on their properties and molecular weight, natural polymers
became a thrust area in majority of investigations in drug delivery
systems (Banker and Anderson, 1987).
Though, as it was mentioned earlier, numerous research
approaches had been directed to utilize this invasive plant as a
natural resource, no one has reported the use of Water hyacinth
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as a pharmaceutical excipient yet. Thus, the present study aims
to investigate possible use of the plant, as an excipient in drug
formulation. Emphasis was given toward developing thrice-daily
sustained-release tablets of a model drug (Metformin HCl), using
different concentrations of the plant powder as rate retarding
agent. The findings may provide possible insights whether we
should utilize Water hyacinth as a new resource, particularly in
pharmaceutical field or perish as wastage that usually we do.
MATERIALS AND METHODS
MATERIALS
The investigation was carried out usingWater hyacinth plants that
were grown in a fresh water pond. Plants of similar shape, size,
and height were selected and washed several times using tap and
bi-distilled water to remove adhering dirt. Only the petiole por-
tions were separated, chopped in small pieces and dried at 60◦C
for 72 h in an oven. Finally they ware crashed and sieved to get
fine powder (Figure 1). The sample was identified by the experts
of Bangladesh National Herbarium, Mirpur, Dhaka, Bangladesh
by Bushra Khan, Principal Scientific officer and tagged with the
Accession No. 38272
Metformin HCl, Lactose monohydrate, and Starch were
gifts from Incepta Pharmaceuticals Ltd., (Savar, Bangladesh).
Microcrystalline cellulose and Magnesium stearate were obtained
from Tasc Pharmaceuticals Ltd., (Mumbai, Maharashtra, India).
All other reagents and chemicals used were of analytical grade.
PREPARATION OF MATRIX TABLETS
Many trials batches were prepared using direct compression
method but found unstable. Finally wet granulation method was
used to prepare the granules and then compressed to prepare
the tablets with different concentration of Water hyacinth and
the detailed compositions of the matrix tablet formulations are
given in Table 1. Matrix tablets, F-1 to F-6 were prepared with 5,
10, 15, 20, 25, and 30% of Water hyacinth powder to the drug.
Briefly, the required amount of drug, polymer, excipients, and
lubricants (magnesium stearate) were weighed out carefully and
mixed thoroughly and the mixtures were then compressed using a
manual single punchmachine (KBRHydraulic Press). Metformin
HCl matrix tablets (500mg) were prepared using 13mm diame-
ter die. Figure 1 shows the process of tablet production from the
collection of Water hyacinth to the tablet compression.
PRE-COMPRESSION EVALUATIONS
Micromeretic properties
Carr’s compressibility index. The simplest way of measurement
of free flow property of powder is compressibility, an indication
of the ease with which a material can be induced to flow is given
by % compressibility, which is calculated as follows (USP 30 and
NF25, 2007):
Carr’s compressibility index, CI (%) = (TD - PD) × 100/TD;
Where TD indicates Tapped density.
Hausner ratio. It is an indirect index to categorize the ease of
powder flow, which is calculated by the following formula (USP
30 and NF25, 2007):
Hausner Ratio = Tapped density/Poured density.
Angle of repose. Funnel method was used to determine the angle
of repose of prepared granules and was calculated using the
following equation (USP 30 and NF25, 2007):
Tan α = height/0.5 base
Fourier Transform Infrared Spectrophotometer (FTIR)
FTIR spectroscopy was used to examine the changes in the chem-
ical composition of the pure drug, crude powder of the petiole
fibers obtained from water hyacinth and the formulated granules
using Shimadzu Fourier transform infrared spectroscopy (FT-
IR, 8400 S, Japan). Appropriate quantity of KBr and sample (in
the ratio 100:0.1) were mixed by grinding in an agate mortar.
Pellets were made with about 100mg mixtures and prepared on
KBr-press under hydraulic pressure (85 KN). The spectra were
scanned over the wave number range of 4000–400 cm−1 at the
ambient temperature.
Differential Scanning Calorimetry (DSC)
DSC is used to obtain information regarding thermally induced
phase transitions characteristic of a sample and to measure the
enthalpy content of these transitions. DSC plays an essential role
in assessing whether the thermal properties of a given sample
are similar to, or qualitatively distinct from, another sample. It
is used to help in determining the occurrence of polymorphism,
drug–excipient compatibility, moisture content, glass transitions,
melting points, and freeze-drying optimization, and in purity
studies and the study of liposomes. Applied to an ensemble of
crystals from a variety of crystallization conditions, DSC thermo-
grams can often be used to distinguish multiple polymorphs from
one another (Adeyeye and Brittain, 2008).
Appropriate quantity of sample was weighed in aluminum pan
and then the aluminum pan was sealed. The sealed aluminum pan
was placed in a Differential Scanning Calorimeter with a thermal
analyzer and the DSC thermograms were reported at a heating
rate of 10◦C/min from 30 to 300◦C. DSCmeasurements were per-
formed in nitrogen atmosphere at flow rate of 20ml/min using
Shimadzu, TA-60 thermal analyzer.
Scanning Electron Microscopy (SEM)
Surface morphology of all formulated granules were investigated
by SEM. At first, a small quantity of sample was placed in a stub (a
device that a sample can be mounted on) and then coated by aut-
ofine coater for platinum coating. After completing the coating
operation, SEM measurements were performed under a scan-
ning electron microscope (JEOL, JSM-6490LA, Japan) and the
diameters were calculated using the image tool analyzer.
POST-COMPRESSION EVALUATION
Weight variation test
Weight variation test was done by weighing 20 tablets individu-
ally, calculating the average weight and comparing the individual
tablet weight to the average weight by using an electronic balance
(Electronic Balance, Adam, UK) (USP 30 and NF25, 2007).
Tablet hardness, thickness, and diameter
The hardness of the tablets was determined by diametral com-
pression using a tablet hardness tester (COPLAY Scientific Ltd.,
UK, Model: TBF1000). Five tablets were randomly taken from
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FIGURE 1 | Water hyacinth processing workflow.
Table 1 | Composition of Metformin HCl SR tablets containing Water hyacinth powder and other excipients.
Formula Metformin Water hyacinth Avicel Lactose Starch Mg stearate Total
No. HCl (mg) powder (mg) [101] (mg) monohydrate (mg) (mg) (mg) (mg)
F-1 200 25(5%) 129 96 40 10 500
F-2 200 50 (10%) 114 86 40 10 500
F-3 200 75(15%) 99 76 40 10 500
F-4 200 100(20%) 84 66 40 10 500
F-5 200 125(25%) 69 56 40 10 500
F-6 200 150(30%) 54 46 40 10 500
each formulation and their thickness was measured using Varnier
calipers (Electronic Digital Caliper, Shanghai shenhan measur-
ing tools co., Ltd.). Tablet diameter is also measured by this way
(Rudnic and Schwartz, 1990).
Tablet friability
The friability (F) of a sample of 20 tablets was measured using
PharmaTest friabilator (Test PTF E, Germany). Twenty tablets
were weighed (W0) and rotated at 25 rpm for 4min. Tablets were
reweighed (W) after removal of fines (dedusted) and the per-
centage of weight loss was calculated using the equation below.
Friability below 1%was considered acceptable (USP 30 andNF25,
2007).
% of friability = W0 − W × 100/W0
PREPARATION OF PHOSPHATE BUFFER
Phosphate buffer at pH 7.4 was prepared with di-sodium hydro-
gen ortho-phosphate and sodium di-hydrogen ortho-phosphate.
To prepare 1 liter of phosphate buffer 1.421 g di-sodium hydro-
gen ortho-phosphate and 0.227 g sodium di-hydrogen ortho-
phosphate were weighed out carefully and dissolved in 1 liter of
distilled water. The pH of the buffer solution was adjusted using
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a pH meter (HANNA Instrument, Model-S412895) (Sutradhar
et al., 2011).
IN VITRO DISSOLUTION STUDIES
In vitro release studies were conducted according to USP type
II dissolution apparatus (PharmaTest, Model: DT 70, Germany)
at the speed of 100 rpm and 37◦C ± 0.5 temperature for 8 h in
which the tablets were subjected to simulated intestinal media
(buffer pH 7.4) to get a simulated picture of the drug release in
the in vivo condition. The samples were analyzed using a UV spec-
trophotometer (HACH Spectrophotometer, Model-DR/4000 μ)
at a wavelength of 234 nm.
RELEASE KINETICS STUDIES
The dissolution data was fitted to popular release mod-
els such as zero-order, first-order, Higuchi, Hixson-crowell,
and Korsemeyer-Peppas equation models to understand
the release kinetics of drug from the formulated matrix
tablets.
Zero-order equation (Wagner, 1969): drug dissolution from
dosage forms which do not disaggregate and release the drug
slowly can be represented by the zero order release kinetics
equation:
Q = Q0 + k0t; Where Q represents the amount of drug dis-
solved in time t, Q0 is the initial amount of the drug in the
solution and k0 is the zero order release constant expressed in
units of concentration/time.
First-order equation (Gibaldi and Feldman, 1967; Wagner,
1969): the release of the drug, which followed first order kinetics,
can be expressed by the first order release kinetics equation:
InQ = InQ0 + k1t; where k1 is the first order rate constant and
t is the time.
Higuchi equation (Higuchi, 1961): Higuchi equation defines
a linear dependence of the active fraction released per unit of
surface (Q) on the square root of time and can be expressed as
Q = kHt1/2; Where Q is the amount of drug release at time t
and kH is the Higuchi release constant.
Hixson–Crowell equation (Hixson and Crowell, 1931): the
following equation was used to calculate the data:
Q1/30 − Q1/3t = kst; Where Q0 is the initial amount of drug
in the matrix tablet, Qt is the amount of drug remaining in the
dosage form at time t, and ks is a constant incorporating the
surface/volume ratio.
Korsmeyer–Peppas equation (Korsmeyer et al., 1983): in order
to define a model, which would represent a better fit for the for-
mulation, dissolution data were further analyzed by Peppas and
Korsmeyer equation:
Qt/Qa = kktn; Where Qt/Qa is a fraction of drug released
at time t, Kk is the release rate constant and n is the release
exponent. In this model, the value of n characterizes the release
mechanism of drug. For the case of cylindrical tablets, n = 0.45
corresponds to a Fickian diffusion mechanism, 0.45 < n < 0.89
to non-Fickian transport, n = 0.89 to Case II (relaxation) trans-
port, and n > 0.89 to super Case II transport which means that
the drug release rate does not change over time and the release is
characterized by zero order release. In this case, the drug release
is dominated by the erosion and swelling of the polymer (Peppas,
1985; Chueh et al., 1995).
Mean Dissolution Time (MDT) can be calculated from disso-
lution data according to the following equation to characterize
the drug release rate from the dosage form and the retarding
efficiency of the polymer (Mockel and Lippold, 1993).
MDT = (n/n + 1)K−1/n; Where n is the release exponent and
K is release rate constant.
RESULTS AND DISCUSSIONS
Before compression, granules were evaluated for bulk density,
tapped density, Angle of repose, Carr’s Index, Hausner Ratio,
FTIR, DSC, and SEM. The prepared sustained release tablets were
evaluated for thickness, diameter, hardness, friability, and unifor-
mity of weight. All these studies were performed in triplicate and
results were recorded (Table 2).
MICROMERETIC PROPERTIES
Carr’s Index and Hausner Ratio of F-1 were excellent, F-2, F-5,
and F-6 were fair and F-3 and F-4 were good flow according to
the specification. Again, on the basis of measured angle of repose,
the flow properties of F-1, F-3, and F-4 were good but the flow
Table 2 | Preformulation study of granules and Mechanical Properties of Metformin HCl Matrix Tablets Containing Water hyacinth.
Formula No. Carr’s Hausner Angle of Average Average Average Friability (%) Weight
index (%) ratio repose (α) hardness (N) thickness (mm) diameter (mm) variation (%)
F-1 9.75 1.108 33.31 152.66 2.812 13.148 0.007 +0.55
−0.41
F-2 19.23 1.23 36.49 133.66 2.86 13.118 0 +0.39
−0.52
F-3 11.86 1.13 32.33 115.06 2.828 13.094 0.007 +0.40
−0.35
F-4 13.33 1.15 33.69 144.8 2.826 13.122 0.009 +0.53
−0.42
F-5 16.66 1.20 36.02 130.16 2.894 13.094 0 +0.71
−1.57
F-6 18.42 1.22 40.14 139.6 2.89 13.126 0.041 +0.51
−0.46
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properties of F-2, F-5, and F-6 were fair according to the specifi-
cation and in this case glidant was added generally to improve the
flow property of the formulation. Hence, wet granulation method
was found best to compress the tablets.
CHARACTERISTICS OF TABLETS
All the formulations were subjected to various quality control
tests as per pharmacopoeial specifications. Post compression
parameters like weight variation, thickness, hardness, and fri-
ability of all the formulations were shown in the Table 2. The
hardness of all the batches were found to be in the range of
115–152 N. The average hardness, thickness and diameter were
measured in all formulations and weight variation was within
the limit of ±5%. Friability values of tablets were less than
1%, which indicated that tablet surfaces are strong enough to
withstand mechanical shock or attrition during storage and
transportation.
FTIR SPECTRA
The pure drug (Metformin HCl), Water hyacinth and formu-
lated granules containing Metformin HCl with Water hyacinth
and various excipients were characterized by FTIR spectroscopy
to test the compatibility. In Figure 2, it is shown that FTIR spectra
of Metformin HCl and formulated granules shown similar char-
acteristic principal peaks at wave numbers 3371 (-NH group),
1418, and 1477 cm−1 (-CH3 group) (Mendham et al., 2000).
Frequencies of functional groups and unique absorption bands
of pure drug remained intact in physical mixture containing
Water hyacinth and other excipients. Hence, there was no major
interaction between the drug and excipients used in the study.
FIGURE 2 | FTIR spectra of Metformin HCl, Water hyacinth, and
Formulated granules.
DSC CURVE
In DSC study the temperature of the peak of Metformin HCl
was found in 233.03◦C and the temperature of the peak of gran-
ules was found in 229.77◦C. The DSC curve of Metformin HCl,
Water hyacinth, and formulated granules containing Metformin
HCl with Water hyacinth are presented in Figure 3.
SEM IMAGE
In Figure 4, the difference in surface morphology of formu-
lated granules (F1–F6) with increasing concentrations of Water
hyacinth is shown.
RELEASE KINETICS MODELS
The result obtained by fitting the dissolution data into the differ-
ent release kinetics models are presented in Table 3 and Figure 5
represents the Zero order release kinetics of Metformin HCl SR
tablet of Water hyacinth. The MDT values of different formula-
tions manifest effect of various polymers shown in Figure 6. The
geometric dependence of diffusion exponent (n) and variations
of n-values with mechanism of diffusion are also listed in Table 3.
F-1 best fits with Hixson Crowell (R2 = 0.994) kinetic models.
The value of release exponent obtained from Korsmeyer model
is 0.241 that indicates that the release pattern of F-1 followed
Fickian (class I) diffusion. F-2 best fits with Korsmeyer (R2 =
0.976) kinetic models. The value of release exponent obtained
from Korsmeyer model is 0.193, which indicates that the release
pattern of F-2 followed Fickian (class I) diffusion. F-3 best fits
with Hixson Crowell (R2 = 0.836) kinetic models. The value of
release exponent obtained from Korsmeyer model is 0.084 that
indicates that the release pattern of F-3 followed Fickian (class I)
diffusion. F-4 best fits with Hixson Crowell (R2 = 0.849) kinetic
models. The value of release exponent obtained from Korsmeyer
model is 0.125, which indicates that the release pattern of F-
4 followed Fickian (class I) diffusion. F-5 best fits with Hixson
Crowell (R2 = 0.983) kinetic models. The value of release expo-
nent obtained from korsmeyer model is 0.091 that indicates that
the release pattern of F-5 followed Fickian (class I) diffusion. F-6
best fits with Korsmeyer (R2 = 0.986) kinetic models. The value
FIGURE 3 | DSC curve of Metformin HCl, Water hyacinth, and
Formulated granules.
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FIGURE 4 | SEM image of Water hyacinth containing granules [(A–F) represents formula F1–F6 respectively].
Table 3 | Interpretation of release rate constants and R2-values for different release kinetics of prepared matrix tablets.
Formula No. Zero order First order Highuchi Korsmeyer Hixson Crowell Best fitted models Mechanism of transport
Ko R2 K1 R2 Kh R2 n R2 KHC R2
F-1 6.406 0.731 −0.051 0.875 21.96 0.925 0.241 0.951 0.089 0.994 Hixson Crowell Fickian (class I) diffusion
F-2 5.589 0.615 −0.041 0.740 20.16 0.862 0.193 0.976 0.065 0.868 Korsmeyer Fickian (class I) diffusion
F-3 4.710 0.483 −0.033 0.578 17.70 0.734 0.084 0.641 0.035 0.836 Hixson Crowell Fickian (class I) diffusion
F-4 5.154 0.538 −0.037 0.649 19.02 0.790 0.125 0.772 0.047 0.849 Hixson Crowell Fickian (class I) diffusion
F-5 4.749 0.486 −0.033 0.583 17.91 0.744 0.091 0.796 −0.140 0.983 Hixson Crowell Fickian (class I) diffusion
F-6 4.688 0.465 −0.033 0.550 17.99 0.737 0.092 0.986 −0.108 0.968 Korsmeyer Fickian (class I) diffusion
of release exponent obtained from Korsmeyer model is 0.092 that
indicates that the release pattern of F-6 followed Fickian (class I)
diffusion.
It is quite understandable to note that one may argue about
the toxicity profile of the plant. Moreover, use of the plant in
the pharmaceutical manufacturing as a component of tablet may
seem a bit confusing as the plant is capable of consuming heavy
metals from the water where it grows. But from a study, Cooly,
and Martin showed that heavy metals are absorbed mostly by
the roots. Accumulation of heavy metals in petioles and leaves
are very low (Cooly and Martin, 1979). As per previous several
researches, it has been found that water hyacinth is acutely or
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FIGURE 5 | Zero order release of Metformin HCl matrix tablets with
Water hyacinth.
FIGURE 6 | Successive fractional dissolution time (minutes) (F1–F6).
sub-chronically non-toxic to mice model (Wu and Sun, 2010;
Wu et al., 2012). Furthermore, the protein concentrate from
the plant may be used as a high quality food ingredient like
digestive biscuits with a reasonable dietary fiber content. The
results of histopathological and haematological evaluation, gen-
eral dissection, and investigations of internal organs of mice did
not show any adverse effect from hyacinth diets (Wu and Sun,
2010; Wu et al., 2012). World Health Organization (WHO) also
reported that the concentrations of all metals in leaf proteins are
within their maximum limits in food additives (WHO Technical
Report, 1989). Lalitha et al. (2012) and Ali et al. (2009) also
showed the non-toxic nature of Water hyacinth extracts (ethyl
acetate, aqueous extract, and methanol fractionate) upon oral
administration.
CONCLUSION
The current study was carried out with an intension to promote
the use of natural resources like Water hyacinth as an excip-
ient with rate retarding ability that can be used in sustained
release tablet formulation. From the release pattern we found
5% of Water hyacinth powder gave desired sustained release of
drug. The drug release patterns were explained in different kinetic
models. F-2 and F-6 best fitted with Korsmeyer kinetic model and
others best fitted with Hixson Crowell kinetic model.
This is one of the most significant results of this work, as no
related data is available elsewhere. From the above study we can
conclude that Water hyacinth can be a very promising natural
resource in Pharmaceutical market as the results are indicating
that can be used as a release retardant polymer in the formula-
tion of sustained release tablets. Nevertheless, further research is
required to establish the optimum width of the water hyacinth
fringe in terms of a pharmaceutical excipient.
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